|
Volumn 23, Issue 2, 2013, Pages 537-542
|
Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus
|
Author keywords
GKAs; Glucokinase; Glucokinase activator; OGTT; T2DM; Type 2 diabetes mellitus; YH GKA
|
Indexed keywords
6 [3 [2 (2,6 DIFLUOROPHENYL)ETHYL] 5 (2 METHOXY 1 METHYLETHOXY)BENZOYLAMINO]NICOTINIC ACID;
ANTIDIABETIC AGENT;
BENZAMIDE DERIVATIVE;
CARBOXYPYRIDINE BENZAMIDE DERIVATIVE;
ENZYME ACTIVATOR;
GLUCOKINASE;
GLUCOSE;
HEXOKINASE;
LIPID;
METFORMIN;
PYRAZOLE BENZAMIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIDIABETIC ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
BINDING AFFINITY;
BINDING SITE;
BODY WEIGHT;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
DISTRIBUTION VOLUME;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG POTENCY;
DRUG STABILITY;
DRUG STRUCTURE;
ENZYME ACTIVITY;
GLUCOSE BLOOD LEVEL;
HORNER WADSWORTH EMMONS REACTION;
HUMAN;
HUMAN CELL;
HYDROGEN BOND;
HYDROPHOBICITY;
IN VITRO STUDY;
INSULIN RELEASE;
LIPID BLOOD LEVEL;
LIVER MICROSOME METABOLISM;
MITSUNOBU REACTION;
MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
ORAL GLUCOSE TOLERANCE TEST;
PHYSICAL CHEMISTRY;
ANIMALS;
BENZAMIDES;
CELLS, CULTURED;
DIABETES MELLITUS, TYPE 2;
DRUG DISCOVERY;
ENZYME ACTIVATION;
GLUCOKINASE;
HUMANS;
HYPOGLYCEMIC AGENTS;
MICE;
MICE, INBRED C57BL;
MICE, OBESE;
MOLECULAR STRUCTURE;
PHENETHYLAMINES;
PYRIDINES;
MUS;
|
EID: 84871717231
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.11.018 Document Type: Article |
Times cited : (33)
|
References (22)
|